Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT.
Pagliuca S, Schmid C, Santoro N, Simonetta F, Battipaglia G, Guillaume T, Greco R, Onida F, Sánchez-Ortega I, Yakoub-Agha I, Kuball J, Hazenberg MD, Ruggeri A; Practice Harmonization and Guidelines Committee and the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Lancet Haematol. 2024 Jun;11(6):e448-e458. doi: 10.1016/S2352-3026(24)00098-X.
Modification of donor lymphocyte infusion: how to improve the outcome?
Wang Y, Xu L, Yan C, Huang X.
Sci China Life Sci. 2019 Sep;62(9):1253-1256. doi: 10.1007/s11427-019-9597-3. Epub 2019 Jul 30.
Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.
Roddie C, Peggs KS.
Expert Opin Biol Ther. 2011 Apr;11(4):473-87. doi: 10.1517/14712598.2011.554811. Epub 2011 Jan 27.
Donor lymphocyte infusions.
Dazzi F, Goldman J.
Curr Opin Hematol. 1999 Nov;6(6):394-9. doi: 10.1097/00062752-199911000-00007.
Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation.
Stamouli M, Gkirkas K, Tsirigotis P.
Immunotherapy. 2016;8(1):57-68. doi: 10.2217/imt.15.100. Epub 2015 Dec 7.
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience.
Uchibori Y, Kurosawa S, Najima Y, Haraguchi K, Sadato D, Hirama C, Sadaga Y, Kondo K, Kato C, Sakai S, Kambara Y, Ouchi F, Shimabukuro M, Jinguji A, Shingai N, Toya T, Shimizu H, Kobayashi T, Harada H, Harada Y, Okuyama Y, Doki N.
Front Immunol. 2025 Jan 29;16:1521895. doi: 10.3389/fimmu.2025.1521895. eCollection 2025.
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant.
Bednarski JJ, Zimmerman C, Berrien-Elliott MM, Foltz JA, Becker-Hapak M, Neal CC, Foster M, Schappe T, McClain E, Pence PP, Desai S, Kersting-Schadek S, Wong P, Russler-Germain DA, Fisk B, Lie WR, Eisele J, Hyde S, Bhatt ST, Griffith OL, Griffith M, Petti AA, Cashen AF, Fehniger TA.
Blood. 2022 Mar 17;139(11):1670-1683. doi: 10.1182/blood.2021013972.
Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review.
Yanagisawa R, Nakazawa Y, Sakashita K, Saito S, Tanaka M, Shiohara M, Shimodaira S, Koike K.
Int J Hematol. 2016 Jan;103(1):107-11. doi: 10.1007/s12185-015-1902-1. Epub 2015 Nov 19.
Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review.
Durer S, Durer C, Shafqat M, Comba IY, Malik S, Faridi W, Aslam S, Ijaz A, Tariq MJ, Fraz MA, Usman M, Khan AY, McBride A, Anwer F.
Immunotherapy. 2019 Apr;11(5):373-378. doi: 10.2217/imt-2018-0104.
Donor Lymphocyte Infusion in Hematologic Malignancies--Good to be Fresh?
Hossain NM, Klumpp T, Ulicny J, Garner M, Kropf PL, Mangan KF, Barta SK, Fung HC, Martin ME.
Clin Lymphoma Myeloma Leuk. 2016 Feb;16(2):111-5. doi: 10.1016/j.clml.2015.10.004. Epub 2015 Nov 3.
